The upregulation of the NAD+ salvage pathway, the main source of NAD+ in most cells, is a common feature in many cancer cells, and nicotinamide phosphoribosyl-transferase (NAMPT), the rate-limiting enzyme of this pathway, is elevated in several human tumors including gastric, glioma and colorectal cancer. The gene discussed is NAMPT; the disease is glioma.